Nothing Special   »   [go: up one dir, main page]

ATE22532T1 - Pharmazeutische zusammensetzung. - Google Patents

Pharmazeutische zusammensetzung.

Info

Publication number
ATE22532T1
ATE22532T1 AT83300622T AT83300622T ATE22532T1 AT E22532 T1 ATE22532 T1 AT E22532T1 AT 83300622 T AT83300622 T AT 83300622T AT 83300622 T AT83300622 T AT 83300622T AT E22532 T1 ATE22532 T1 AT E22532T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
glutathione
cancer
compositions
conjunction
Prior art date
Application number
AT83300622T
Other languages
English (en)
Inventor
David Frederick Horrobin
Original Assignee
Efamol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Ltd filed Critical Efamol Ltd
Application granted granted Critical
Publication of ATE22532T1 publication Critical patent/ATE22532T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
AT83300622T 1982-03-01 1983-02-08 Pharmazeutische zusammensetzung. ATE22532T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8205938 1982-03-01
EP83300622A EP0087865B1 (de) 1982-03-01 1983-02-08 Pharmazeutische Zusammensetzung

Publications (1)

Publication Number Publication Date
ATE22532T1 true ATE22532T1 (de) 1986-10-15

Family

ID=10528694

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83300622T ATE22532T1 (de) 1982-03-01 1983-02-08 Pharmazeutische zusammensetzung.

Country Status (7)

Country Link
EP (1) EP0087865B1 (de)
JP (1) JPS58159418A (de)
AT (1) ATE22532T1 (de)
AU (1) AU554413B2 (de)
CA (1) CA1203483A (de)
DE (1) DE3366506D1 (de)
IE (1) IE54558B1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69782A (en) * 1982-09-22 1987-12-20 Sentrachem Ltd Compositions for preventing cancerous conditions comprising precursors of eicosanoid mixtures and a dietary supplement containing them
GB8326130D0 (en) * 1983-09-29 1983-11-02 Efamol Ltd Topical preparations containing tars and fatty acids
IT1200467B (it) * 1985-05-06 1989-01-18 Boehringer Biochemia Srl Formulazione farmaceutica
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
US5118493A (en) * 1986-05-02 1992-06-02 Brigham And Women's Hospital Composition having reduced nephrotoxocity comprising a fatty acid containing component and cyclosporine
JP2574354B2 (ja) * 1986-05-02 1997-01-22 ブリガム・アンド・ウイメンズ・ホスピタル 脂肪酸含有成分およびサイクロスポリンよりなる腎毒性の減少した組成物
DE3615710A1 (de) * 1986-05-09 1987-11-26 Hoechst Ag Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
EP0457950B1 (de) * 1990-05-23 1993-10-20 Societe Des Produits Nestle S.A. Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen
US5214062A (en) * 1992-04-08 1993-05-25 Clintec Nutrition Co. Method and composition for treating immune disorders, inflammation and chronic infections
CN1056082C (zh) * 1994-04-08 2000-09-06 北京市兴大科学系统公司 一种抗癌药
DE19903095C2 (de) * 1999-01-27 2003-05-22 Nutrinova Gmbh Gewinnung von gamma-Linolensäure aus Protozoen der Gattung Colpidium
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
MX2016015961A (es) 2014-06-04 2017-04-05 Dignity Sciences Ltd Composiciones farmacéuticas que comprenden ácido dihomo-gamma-linolénico (dgla) y uso de las mismas.
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
IE51145B1 (en) * 1980-03-07 1986-10-15 Efamol Ltd Pharmaceutical and dietary compositions
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
DE3366506D1 (en) 1986-11-06
AU1145483A (en) 1983-09-08
AU554413B2 (en) 1986-08-21
IE54558B1 (en) 1989-11-22
EP0087865A2 (de) 1983-09-07
CA1203483A (en) 1986-04-22
JPS58159418A (ja) 1983-09-21
EP0087865B1 (de) 1986-10-01
IE830265L (en) 1983-09-01
EP0087865A3 (en) 1984-03-07

Similar Documents

Publication Publication Date Title
DE3486235D1 (de) Fettsäure-Zusammensetzungen.
GR3006068T3 (de)
ATE22532T1 (de) Pharmazeutische zusammensetzung.
NL191332C (nl) Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur.
FI893805A0 (fi) Fettsyrakomposition.
ATE32430T1 (de) Pharmazeutische zusammensetzungen.
ES2107622T3 (es) Medicamento para el tratamiento de la distrofia vulvar o la sequedad vaginal.
AU633603B2 (en) Pharmaceutical compositions
DE3875286D1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
ATE22533T1 (de) Pharmazeutische zusammensetzung.
ATE22804T1 (de) Pharmazeutische zusammensetzung.
ATE70183T1 (de) Topische zubereitungen mit gehalt an teer und fettsaeuren.
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
NO932843L (no) Farmasoeytiske preparater
FI885277A (fi) 2,4-diklor-5-fluorbenzoyl -aettikssyraetylester.
IT8819401A0 (it) Composizioni aminoacidiche perfezionate per il trattamento specifico delle insufficienze epatiche.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee